Diagnostic Biomarkers for Checkpoint Inhibitor-related Pneumonitis — Stella

Clinical trial discovery in plain English. Data sourced from ClinicalTrials.gov.

About Browse conditions ClinicalTrials.gov ↗

Stella is not a medical provider and does not give medical advice. AI-generated summaries are for informational purposes only. Always consult your doctor before making any healthcare decisions.

Diagnostic Biomarkers for Checkpoint Inhibitor-related Pneumonitis — Stella

Home/Checkpoint Inhibitor-related Pneumonitis/

View on ClinicalTrials.gov

Recruiting

Back to Checkpoint Inhibitor-related Pneumonitis trials

Trial locations(1 site)

China

The First Affiliated Hospital of Guangzhou Medical University, Guangzhou, Guangdong

Key details

Sponsor

Zhou Chengzhi

Enrollment target

~60 participants

Started

January 2026

Primary completion

January 2027

Age range

18 Years and older

Last updated February 2026

Interested in joining?

Tell us you're interested and we'll help connect you with the research team. We'll never share your email without your permission.

Your name

Email address

Stella acts as an intermediary. Researcher contact info is never exposed.

Follow this trial

Get notified in plain English when this trial's status changes. No account required.